- Home
- NUVB vs SHLS Comparison
NUVB vs SHLS Comparison
Compare NUVB & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- SHLS
- Stock Information
- Founded
- NUVB 2018
- SHLS 1996
- Country
- NUVB United States
- SHLS United States
- Employees
- NUVB N/A
- SHLS N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- SHLS Semiconductors
- Sector
- NUVB Health Care
- SHLS Technology
- Exchange
- NUVB Nasdaq
- SHLS Nasdaq
- Market Cap
- NUVB 850.3M
- SHLS 951.6M
- IPO Year
- NUVB N/A
- SHLS 2021
- Fundamental
- Price
- NUVB $2.62
- SHLS $4.43
- Analyst Decision
- NUVB Strong Buy
- SHLS Buy
- Analyst Count
- NUVB 6
- SHLS 18
- Target Price
- NUVB $6.17
- SHLS $12.14
- AVG Volume (30 Days)
- NUVB 2.1M
- SHLS 5.3M
- Earning Date
- NUVB 11-06-2024
- SHLS 11-12-2024
- Dividend Yield
- NUVB N/A
- SHLS N/A
- EPS Growth
- NUVB N/A
- SHLS N/A
- EPS
- NUVB N/A
- SHLS 0.19
- Revenue
- NUVB $2,162,000.00
- SHLS $422,657,000.00
- Revenue This Year
- NUVB N/A
- SHLS N/A
- Revenue Next Year
- NUVB N/A
- SHLS $17.85
- P/E Ratio
- NUVB N/A
- SHLS $22.74
- Revenue Growth
- NUVB N/A
- SHLS N/A
- 52 Week Low
- NUVB $1.22
- SHLS $4.07
- 52 Week High
- NUVB $4.16
- SHLS $17.50
- Technical
- Relative Strength Index (RSI)
- NUVB 49.69
- SHLS 38.54
- Support Level
- NUVB $2.44
- SHLS $4.07
- Resistance Level
- NUVB $3.07
- SHLS $4.53
- Average True Range (ATR)
- NUVB 0.17
- SHLS 0.45
- MACD
- NUVB -0.01
- SHLS -0.13
- Stochastic Oscillator
- NUVB 43.26
- SHLS 17.58
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About SHLS Shoals Technologies Group Inc.
Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.